Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Hrdlicková R[au]:

RNA-Seq methods for transcriptome analysis. Hrdlickova R et al. Wiley Interdiscip Rev RNA. (2017)

Distribution of indications and procedures within the framework of centers participating in the WAA apheresis registry. Stegmayr B et al. Transfus Apher Sci. (2017)

Adverse events in apheresis: An update of the WAA registry data. Mörtzell Henriksson M et al. Transfus Apher Sci. (2016)

Search results

Items: 27

1.

Evaluation of health and quality of life in apheresis patients - data from the WAA register.

Goto J, Newman E, Witt V, Deeren D, Blaha M, Lanska M, Gasova Z, Bhuiyan-Ludvikova Z, Hrdlickova R, Ramlow W, Prophet H, Liumbruno G, Griskevicius A, Audzijoniene J, Vrielink H, Aandahl A, Sanchez SO, Strineholm V, Berlin G, Mörtzell-Henriksson M, Stegmayr BG, Eich T, Ilhan O.

Transfus Apher Sci. 2019 Sep 5. pii: S1473-0502(19)30188-0. doi: 10.1016/j.transci.2019.08.024. [Epub ahead of print]

PMID:
31519525
2.

ADAMTS13 kinetics after therapeutic plasma exchange and plasma infusion in patients with Upshaw-Schulman syndrome.

Kovarova P, Hrdlickova R, Blahutova S, Cermakova Z.

J Clin Apher. 2019 Feb;34(1):13-20. doi: 10.1002/jca.21664. Epub 2018 Nov 5. Erratum in: J Clin Apher. 2019 Aug;34(4):519.

PMID:
30394580
3.

Distribution of indications and procedures within the framework of centers participating in the WAA apheresis registry.

Stegmayr B, Mörtzell Henriksson M, Newman E, Witt V, Derfler K, Leitner G, Eloot S, Dhondt A, Deeren D, Rock G, Ptak J, Blaha M, Lanska M, Gasova Z, Bhuiyan-Ludvikova Z, Hrdlickova R, Ramlow W, Prophet H, Liumbruno G, Mori E, Griskevicius A, Audzijoniene J, Vrielink H, Rombout-Sestrienkova E, Aandahl A, Sikole A, Tomaz J, Lalic K, Bojanic I, Strineholm V, Brink B, Berlin G, Dykes J, Toss F, Nilsson T, Knutson F, Ramsauer B, Wahlstrom A.

Transfus Apher Sci. 2017 Feb;56(1):71-74. doi: 10.1016/j.transci.2016.12.023. Epub 2017 Jan 4. Review.

PMID:
28162978
4.

RNA-Seq methods for transcriptome analysis.

Hrdlickova R, Toloue M, Tian B.

Wiley Interdiscip Rev RNA. 2017 Jan;8(1). doi: 10.1002/wrna.1364. Epub 2016 May 19. Review.

5.

Adverse events in apheresis: An update of the WAA registry data.

Mörtzell Henriksson M, Newman E, Witt V, Derfler K, Leitner G, Eloot S, Dhondt A, Deeren D, Rock G, Ptak J, Blaha M, Lanska M, Gasova Z, Hrdlickova R, Ramlow W, Prophet H, Liumbruno G, Mori E, Griskevicius A, Audzijoniene J, Vrielink H, Rombout S, Aandahl A, Sikole A, Tomaz J, Lalic K, Mazic S, Strineholm V, Brink B, Berlin G, Dykes J, Toss F, Axelsson CG, Stegmayr B, Nilsson T, Norda R, Knutson F, Ramsauer B, Wahlström A.

Transfus Apher Sci. 2016 Feb;54(1):2-15. doi: 10.1016/j.transci.2016.01.003. Epub 2016 Jan 8.

6.

Multiple tumor suppressor microRNAs regulate telomerase and TCF7, an important transcriptional regulator of the Wnt pathway.

Hrdličková R, Nehyba J, Bargmann W, Bose HR Jr.

PLoS One. 2014 Feb 14;9(2):e86990. doi: 10.1371/journal.pone.0086990. eCollection 2014.

7.

Panorama of adverse events during cytapheresis.

Stegmayr B, Ptak J, Nilsson T, Berlin G, Mirea V, Axelsson CG, Griskevicius A, Centoni P, Liumbruno G, Audzijoniene J, Mokvist K, Lassen E, Knutson F, Norda R, Mörtzell M, Prophet H, Ramlow W, Blaha M, Witt V, Efvergren M, Tomaz J, Newman E, Eloot S, Dhondt A, Lalic K, Sikole A, Derfler K, Hrdlickova R, Tomsova H, Gasova Z, Bhuiyan-Ludvikova Z, Ramsauer B, Vrielink H.

Transfus Apher Sci. 2013 Apr;48(2):155-6. doi: 10.1016/j.transci.2013.02.014. Epub 2013 Mar 13. No abstract available.

PMID:
23809812
8.

[A case history of acquired haemophilia A].

Cermáková Z, Hrdličková R, Blahutová S, Ligová A.

Vnitr Lek. 2013 Apr;59(4):313-6. Czech.

PMID:
23711058
9.

Transfusion-related acute lung injury: report of two cases.

Čermáková Z, Kořískta M, Blahutová Š, Dvořáčková J, Brát R, Valkovský I, Hrdličková R.

Prague Med Rep. 2012;113(4):294-8.

PMID:
23249661
10.

Alternatively spliced telomerase reverse transcriptase variants lacking telomerase activity stimulate cell proliferation.

Hrdlicková R, Nehyba J, Bose HR Jr.

Mol Cell Biol. 2012 Nov;32(21):4283-96. doi: 10.1128/MCB.00550-12. Epub 2012 Aug 20.

11.

Insights into the evolution of mammalian telomerase: platypus TERT shares similarities with genes of birds and other reptiles and localizes on sex chromosomes.

Hrdličková R, Nehyba J, Lim SL, Grützner F, Bose HR Jr.

BMC Genomics. 2012 Jun 1;13:216. doi: 10.1186/1471-2164-13-216.

12.

Dynamic evolution of immune system regulators: the history of the interferon regulatory factor family.

Nehyba J, Hrdlicková R, Bose HR.

Mol Biol Evol. 2009 Nov;26(11):2539-50. doi: 10.1093/molbev/msp167. Epub 2009 Jul 28.

13.

[Therapeutic plasma exchange in the treatment of the hereditary thrombotic thrombocytopenic purpura].

Cermáková Z, Korístka M, Korístková B, Hrdlicková R, Suláková T, Furková J, Kovárová P.

Cas Lek Cesk. 2009;148(10):493-6. Czech.

PMID:
20662412
14.

Regulation of telomerase activity by interferon regulatory factors 4 and 8 in immune cells.

Hrdlicková R, Nehyba J, Bose HR Jr.

Mol Cell Biol. 2009 Feb;29(3):929-41. doi: 10.1128/MCB.00961-08. Epub 2008 Dec 1.

15.

Targeted disruption of Mib2 causes exencephaly with a variable penetrance.

Wu JI, Rajendra R, Barsi JC, Durfee L, Benito E, Gao G, Kuruvilla M, Hrdlicková R, Liss AS, Artzt K.

Genesis. 2007 Nov;45(11):722-7.

PMID:
17987667
16.

Mechanism of telomerase activation by v-Rel and its contribution to transformation.

Hrdlicková R, Nehyba J, Liss AS, Bose HR Jr.

J Virol. 2006 Jan;80(1):281-95.

17.
18.

Interferon regulatory factor 4 contributes to transformation of v-Rel-expressing fibroblasts.

Hrdlicková R, Nehyba J, Bose HR Jr.

Mol Cell Biol. 2001 Oct;21(19):6369-86.

19.

The chicken RelB transcription factor has transactivation sequences and a tissue-specific expression pattern that are distinct from mammalian RelB.

Piffat KA, Hrdlicková R, Nehyba J, Ikeda T, Liss A, Huang S, Sif S, Gilmore TD, Bose HR Jr.

Mol Cell Biol Res Commun. 2001 Sep;4(5):266-75.

PMID:
11529676
20.

Degradation of proto-oncoprotein c-Rel by the ubiquitin-proteasome pathway.

Chen E, Hrdlickova R, Nehyba J, Longo DL, Bose HR Jr, Li CC.

J Biol Chem. 1998 Dec 25;273(52):35201-7. Erratum in: J Biol Chem 1999 May 14;274(20):14514.

21.
25.

In vivo evolution of c-rel oncogenic potential.

Hrdlicková R, Nehyba J, Humphries EH.

J Virol. 1994 Apr;68(4):2371-82.

27.

Supplemental Content

Loading ...
Support Center